Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Membership Application

If you haven't already done so, please review the benefits of IMACS membership

All required fields have the word (Required) after the label.

Optional information is used to facilitate use of information on IMACS members.

Demographics

Applicant Information

Membership Type
Associate Members are trainee members (students, fellows), research assistants, or members of non-profit or for-profit organizations.
Full Members may participate in IMACS committees (voted positions), and participate in voting on IMACS committee members and policies.

Affiliation Information

Affiliation (check all that apply)

Primary Affiliation Address

Optional Information

Please complete the optional information below to facilitate communication among IMACS members.

Myositis Research

Are you interested in Myositis research?
Are you interested in Myositis research?
If yes, what areas of myositis research interest you? Select all that apply:
If yes, what areas of myositis research interest you? Select all that apply:

Myositis Patients

Are you responsible for the clinical area of myositis patients?
Are you responsible for the clinical area of myositis patients?
If yes, what types of myositis patients are under your care?
If yes, what types of myositis patients are under your care?
Please select all clinical forms of myositis that you care for from the following:
Please select all clinical forms of myositis that you care for from the following:

Scientific Interest Groups

Are you interested in joining any of the following Scientific Interest Groups?
Are you interested in joining any of the following Scientific Interest Groups?
×

Calcinosis in Juvenile and Adult Dermatomyositis

Calcinosis can be a devastating complication in juvenile and adult dermatomyositis leading to significant morbidity. Since there are no effective therapies for calcinosis, the development of novel therapeutic agents is desperately needed. The aims of this group are to advance our understanding of the etiology, pathogenesis, assessment, and treatment of calcinosis in juvenile and adult dermatomyositis.
×

Extension of SHARE consensus for management of JDM

The European Initiative, called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE), developed recommendations to optimize and disseminate diagnostic and management regimens in Europe, for several conditions, including juvenile dermatomyositis (JDM). The aims of these recommendations were to develop the ‘best practices’ for the treatment for these conditions, to produce a standard of care or ‘best practices’ for patient care throughout Europe. The IMACS SHARE Scientific Interest Group was formed to review and augment the JDM SHARE recommendations and consider their applicability and feasibility internationally, including for patients outside of Europe.
×

Inclusion Body Myositis

Sporadic Inclusion body myositis (IBM) is a gradually progressive idiopathic inflammatory myopathy, which typically leads to severe disability, including difficulty using hands, impaired mobility, and dysphagia. There is currently no proven treatment for patients with IBM. Lack of validated outcome measures and objective biomarkers are major limitations in IBM clinical trials. This group will focus on examining outcome measures in IBM in order to optimize them for future clinical trials.
×

International Classification of Diseases (ICD)

The proper billing and coding of a disease is important for the management of patients, and for research. This group is working to optimize the coding systems that are of importance to the idiopathic inflammatory myopathies. We have previously received ICD-10-CM approval and implementation for codes for dermatomyositis and dermatomyositis without myopathy, and are working on additional ICD coding issues.
×

Myositis Autoantibodies

The discovery of new myositis autoantibodies that identify distinct patterns of disease within the myositis spectrum has been a major advance in the field in recent years. The availability of reliable assays to measure myositis autoantibodies in routine clinical practice is an ongoing unmet need. This group will promote knowledge to take full advantage of the clinical utility of myositis autoantibody testing, and provide a forum for interchange of ideas and collaboration to identify important areas for future research.
×

Rehabilitation and Exercise Group

This group is devoted to studying the effect of exercise therapy and rehabilitation on the disease and vice versa in juvenile and adult myositis. To this end, the group has focused on developing and validating measures for fatigue and endurance, muscle strength testing, and functional testing for juvenile and adult myositis that can be used as endpoints in such studies. Currently, a large focus of the group’s work is to develop International Guidelines on Exercise for all forms of myositis.

Curriculum Vitae or NIH BioSketch

Please have your CV or NIH BioSketch updated before you begin the membership application. Your CV or NIH BioSketch is required for membership approval as a FULL or ASSOCIATE member of IMACS. Please attach your CV or NIH BioSketch in one of the following file formats:

  • Adobe PDF document (filename.pdf)
  • Word document (filename.doc or filename.docx)
  • Rich Text Format (filename.rtf)
Back
to Top